Evidence map›Paper›PMID 22013357›Full record

ArticleMens sana monographs2008

Medicine as a corporate enterprise: a welcome step?

Murali Poduval, Jayita Poduval

Abstract read
In one paragraph

Article in Mens sana monographs, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Frozen in time: Breaking free from past family practice models.Canadian family physician Medecin de famille canadien · 2026
    Article
  2. Article
  3. Radiologist's profile-yesterday, today, and tomorrow.The Indian journal of radiology & imaging · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Murali PoduvalLecturer, Department of Orthopedics, Seth G.S. Medical College and The KEM Group of Hospitals, Mumbai, Editor, IJCP's Asian Journal of Orthopedics and Rheumatology.
Jayita Poduval

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The medical profession is set for a change. It is being redesigned as a corporate enterprise. The health-care industry has proved to be lucrative and therefore has seen the entry of newer players from the corporate field into the market. The "Medical-Industrial complex" has led to the commercialization of health care well beyond what traditional practitioners would consider ideal. Medicine is being treated as a business, with cost curtailment measures and profit margins often dictating physicians' choices. A number of factors decide working environment in a corporate setup, all of which may affect the sacrosanct physician-doctor relationship and "physician" ethics. On the other side, the ability of the corporate sector to bring about a welcome change in the health-care sector in terms of availability of newer modalities of management, implementation of preventive and personalized health-care programme and, at the same time, adding to the comfort of the treating physician cannot be ignored.

Indexed as

BusinessCorporate Enterprise in MedicineCorporate Trust HospitalsHealth CareLarge Hospital ChainsManaged Health CareMedical Profession and Corporate CultureMedicinePhysicians in Corporate Setup

Identifiers

PMID22013357
PMCPMC3190548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.